Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $189.31 million. The enterprise value is $106.04 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 50.75 million shares outstanding. The number of shares has increased by 2.48% in one year.
| Current Share Class | 50.75M |
| Shares Outstanding | 50.75M |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 20.44% |
| Owned by Institutions (%) | 33.88% |
| Float | 31.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| Forward PS | 2.02 |
| PB Ratio | 1.98 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.18, with a Debt / Equity ratio of 0.37.
| Current Ratio | 10.18 |
| Quick Ratio | 9.53 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.69 |
Financial Efficiency
Return on equity (ROE) is -45.36% and return on invested capital (ROIC) is -21.28%.
| Return on Equity (ROE) | -45.36% |
| Return on Assets (ROA) | -19.40% |
| Return on Capital (ROIC) | -21.28% |
| Revenue Per Employee | $371,696 |
| Profits Per Employee | -$235,290 |
| Employee Count | 214 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 1.55 |
Taxes
In the past 12 months, Sight Sciences has paid $208,000 in taxes.
| Income Tax | 208,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.78% in the last 52 weeks. The beta is 2.73, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.73 |
| 52-Week Price Change | +65.78% |
| 50-Day Moving Average | 5.54 |
| 200-Day Moving Average | 5.79 |
| Relative Strength Index (RSI) | 30.24 |
| Average Volume (20 Days) | 267,380 |
Short Selling Information
The latest short interest is 1.12 million, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 1.12M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 2.21% |
| Short % of Float | 3.61% |
| Short Ratio (days to cover) | 7.27 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $79.54 million and -$50.35 million in losses. Loss per share was -$1.01.
| Revenue | 79.54M |
| Gross Profit | 67.70M |
| Operating Income | -49.71M |
| Pretax Income | -52.20M |
| Net Income | -50.35M |
| EBITDA | -49.02M |
| EBIT | -49.71M |
| Loss Per Share | -$1.01 |
Full Income StatementBalance Sheet
The company has $118.56 million in cash and $35.29 million in debt, giving a net cash position of $83.28 million or $1.64 per share.
| Cash & Cash Equivalents | 118.56M |
| Total Debt | 35.29M |
| Net Cash | 83.28M |
| Net Cash Per Share | $1.64 |
| Equity (Book Value) | 94.96M |
| Book Value Per Share | 1.88 |
| Working Capital | 126.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.38 million and capital expenditures -$512,000, giving a free cash flow of -$25.89 million.
| Operating Cash Flow | -25.38M |
| Capital Expenditures | -512,000 |
| Free Cash Flow | -25.89M |
| FCF Per Share | -$0.51 |
Full Cash Flow StatementMargins
Gross margin is 85.11%, with operating and profit margins of -62.50% and -63.30%.
| Gross Margin | 85.11% |
| Operating Margin | -62.50% |
| Pretax Margin | -63.04% |
| Profit Margin | -63.30% |
| EBITDA Margin | -61.62% |
| EBIT Margin | -62.50% |
| FCF Margin | -45.76% |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | -26.60% |
| FCF Yield | -13.67% |
Analyst Forecast
The average price target for Sight Sciences is $6.80, which is 82.31% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.80 |
| Price Target Difference | 82.31% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of 0.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.33 |
| Piotroski F-Score | 3 |